Nanoplastics, minute particles with dimensions in the nanometer range, have emerged as a topic of concern within the pharmaceutical industry due to their potential impact on drug delivery and overall safety. These tiny plastic particles, often originating from the breakdown of larger plastic materials, can interact with pharmaceutical formulations in unforeseen ways. In drug delivery systems, nanoplastics may unintentionally become carriers for therapeutic agents, altering drug release kinetics and distribution patterns. Moreover, concerns exist regarding the potential toxicological effects of nanoplastics, as their small size allows them to penetrate biological barriers, raising questions about their long-term impact on human health.
Researchers and pharmaceutical professionals are actively exploring methodologies to detect and mitigate the presence of nanoplastics in pharmaceutical products, aiming to ensure the efficacy and safety of medications. As the understanding of nanoplastics continues to evolve, it underscores the importance of comprehensive assessments in pharmaceutical development to address potential challenges associated with these minuscule plastic particles.
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Huiqin Yang
ICON Clinical Research Ltd, United KingdomSubmit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Antibody proteases as translational tools of the next step generation to be applied for biopharmacy related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Cognitivevoice: Novel machine learning model leveraging acoustic features to predict future cognitive decline in Parkinson’s Disease
Aadya Daga, Hamilton High School, United States
Title : Platelet-activating factor-receptor pathway mediates solar radiation-induced extracellular vesicle release in human keratinocytes
Ravi P Sahu, Wright State University, United States